Skip to main content
Equibles
MED logo

MED · Medifast Inc · Webcasts, Transcripts & Audio

Track MED — free

Use MED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.67 -0.06 (-0.51%) At close · Oct 5
Rebalance outlook locked
Market Cap
$136.07M
Shares
11.18M
Volume · Oct 5 65.8K Avg daily vol (3M) 152.42K

Medifast Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Medifast Inc (MED), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼5.6% $390.40M $36.16M '22 Q3 22-11-03 ▼10.7% $337.25M $26.52M '22 Q4 23-02-21 ▼16.4% $348.98M $39.97M '23 Q1 23-05-01 ▼34.7% $296.19M $30.28M '23 Q2 23-08-07 ▼39.6% $235.87M $23.13M '23 Q3 23-11-06 ▼43.4% $191.01M $6.04M '23 Q4 24-02-20 ▼49.9% $174.74M $8.32M '24 Q1 24-04-29 ▼43.1% $168.56M −$8.15M '24 Q2 24-08-05 ▼40.6% $140.16M $1.13M '24 Q3 24-11-04 ▼37.7% $119.00M $800,000 '24 Q4 25-02-18 ▼33.8% $115.73M −$772,000 '25 Q1 25-04-28 ▼37.4% $105.56M $2.48M '25 Q2 25-08-04 ▼36.2% $89.41M −$2.26M '25 Q3 25-11-03 ▼36.9% $75.10M −$18.12M '25 Q4 26-02-17 ▼34.3% $76.04M −$2.12M '26 Q1 26-05-04 LATEST ▼27.6% $76.38M −$3.10M '26 Q2 26-08-03
Earnings call
FY26 · Q2
2026-08-03
Medifast Inc (MED) Q2 2026 Earnings Call Transcript
Positive tone Trilovie Brand Launch & Product Transition Metabolic Health Positioning & GLP-1 Revenue Stabilization
Revenue
$76.38M
▼ 27.6% YoY
Diluted EPS
$-0.28
▼ 227.3% YoY
Gross margin
69.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Medifast Inc (MED) Q1 2026 Earnings Call Transcript
Positive tone Metabolic health repositioning Coach productivity and field execution Body composition and clinical outcomes
Revenue
$76.04M
▼ 34.3% YoY
Diluted EPS
$-0.19
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Medifast Inc (MED) Q4 2025 Earnings Call Transcript
Positive tone Metabolic Health Repositioning Leadership Transition Coach Productivity Improvement
Revenue
$75.10M*
▼ 36.9% YoY
Gross margin
69.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Medifast Inc (MED) Q3 2025 Earnings Call Transcript
Positive tone Coach network and coaching Metabolic health positioning EDGE leadership program
Revenue
$89.41M
▼ 36.2% YoY
Diluted EPS
$-0.21
▼ 310% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Medifast Inc (MED) Q2 2025 Earnings Call Transcript
Positive tone GLP-1 positioning and opportunity Clinical research and metabolic health science Coach productivity and growth initiatives
Revenue
$105.56M
▼ 37.4% YoY
Diluted EPS
$0.22
Gross margin
72.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-28
Medifast Inc (MED) Q1 2025 Earnings Call Transcript
Positive tone GLP-1 drugs impact and opportunity Coach-led business model and productivity Q1 financial results
Revenue
$115.73M
▼ 33.8% YoY
Diluted EPS
$-0.07
▼ 109.2% YoY
Gross margin
72.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Medifast Inc (MED) Q4 2024 Earnings Call Transcript
Balanced tone GLP-1 market adaptation Coach productivity trends Cash flow and balance sheet
Revenue
$119.00M*
▼ 37.7% YoY
Gross margin
74.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Medifast Inc (MED) Q3 2024 Earnings Call Transcript
Cautious tone GLP-1 market transformation Coach network and training LifeMD partnership
Revenue
$140.16M
▼ 40.6% YoY
Diluted EPS
$0.10
▼ 95.3% YoY
Gross margin
75.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Medifast Inc (MED) Q2 2024 Earnings Call Transcript
Cautious tone GLP-1 market opportunity and pivot Balance sheet and capital allocation Company-led advertising and customer acquisition
Revenue
$168.56M
▼ 43.1% YoY
Diluted EPS
$-0.75
▼ 127.1% YoY
Gross margin
73.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-29
Medifast Inc (MED) Q1 2024 Earnings Call Transcript
Positive tone LifeMD collaboration and integrated solution OPTAVIA coaches and community support Financial results and quarterly performance
Revenue
$174.74M
▼ 49.9% YoY
Diluted EPS
$0.76
▼ 79.3% YoY
Gross margin
72.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Medifast Inc (MED) Q4 2023 Earnings Call Transcript
Positive tone Q1 EPS guidance range / execution uncertainty GLP-1 / LifeMD collaboration Fuel for the Future cost program
Revenue
$191.01M*
▼ 43.4% YoY
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Medifast Inc (MED) Q3 2023 Earnings Call Transcript
Revenue
$235.87M
▼ 39.6% YoY
Diluted EPS
$2.12
▼ 35.2% YoY
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Medifast Inc (MED) Q2 2023 Earnings Call Transcript
Revenue
$296.19M
▼ 34.7% YoY
Diluted EPS
$2.77
▼ 19% YoY
Gross margin
71.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-01
Medifast Inc (MED) Q1 2023 Earnings Call Transcript
Revenue
$348.98M
▼ 16.4% YoY
Diluted EPS
$3.67
▲ 2.2% YoY
Gross margin
70.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Medifast Inc (MED) Q4 2022 Earnings Call Transcript
Revenue
$337.25M*
▼ 10.7% YoY
Gross margin
69.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Medifast Inc (MED) Q3 2022 Earnings Call Transcript
Revenue
$390.40M
▼ 5.6% YoY
Diluted EPS
$3.27
▼ 8.1% YoY
Gross margin
72.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Medifast Inc (MED) Q2 2022 Earnings Call Transcript
Revenue
$453.33M
▲ 15% YoY
Diluted EPS
$3.42
▼ 13.6% YoY
Gross margin
71.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
Medifast Inc (MED) Q1 2022 Earnings Call Transcript
Revenue
$417.60M
▲ 22.6% YoY
Diluted EPS
$3.59
▲ 3.8% YoY
Gross margin
72.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Medifast Inc (MED) Q4 2021 Earnings Call Transcript
Revenue
$377.83M*
▲ 42.6% YoY
Gross margin
73.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Medifast Inc (MED) Q3 2021 Earnings Call Transcript
Revenue
$413.39M
▲ 52.3% YoY
Diluted EPS
$3.56
▲ 22.3% YoY
Gross margin
74.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Medifast Inc (MED) Q2 2021 Earnings Call Transcript
Revenue
$394.19M
▲ 79.2% YoY
Diluted EPS
$3.96
▲ 112.9% YoY
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Medifast Inc (MED) Q1 2021 Earnings Call Transcript
Revenue
$340.67M
▲ 90.9% YoY
Diluted EPS
$3.46
▲ 121.8% YoY
Gross margin
73.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Medifast Inc (MED) Q4 2020 Earnings Call Transcript
Revenue
$264.91M
▲ 55.3% YoY
Diluted EPS
$2.36
▲ 42.2% YoY
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Medifast Inc (MED) Q3 2020 Earnings Call Transcript
Revenue
$271.47M
▲ 42.8% YoY
Diluted EPS
$2.91
▲ 120.5% YoY
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Medifast Inc (MED) Q2 2020 Earnings Call Transcript
Revenue
$220.00M
▲ 17.6% YoY
Diluted EPS
$1.86
▲ 6.3% YoY
Gross margin
72.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Medifast Inc (MED) Q1 2020 Earnings Call Transcript
Revenue
$178.46M
▲ 7.6% YoY
Diluted EPS
$1.56
▼ 8.2% YoY
Gross margin
75.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-26
Medifast Inc (MED) Q4 2019 Earnings Call
Revenue
$170.63M
▲ 17% YoY
Diluted EPS
$1.66
▲ 27.7% YoY
Gross margin
75.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 910329 CUSIP 58470H101 13F (30d) 2 filings 2 filers Visit website Investor relations